This site is intended for UK healthcare professionals

 

The evolving role of a Cardio-oncology Clinical Nurse Specialist

15 May 2025
The increasing survival rate of cancer patients along with the increase in the toxicity profile of treatments has resulted in a growing demand for specialist cardio-oncology care. Listen to Priya Reehal, Clinical Nurse Specialist at the Royal Brompton Hospital Centre of Excellence for Cardio-oncology, discuss her role, present the findings of a decade-long study into the number of patients referred for cancer therapy–related cardiac dysfunction, and explain why we need more cardio-oncology centres of excellence across the UK.
Speaker

Priya Reehal  Cardiology-oncology Clinical Nurse Specialist, Royal Brompton Hospital, London

Learning objectives

  • To discover the important role that cardio-oncology has to play as a sub-specialty of cardiology
  • To learn about cardiovascular toxicity as a growing medical problem due to increased cancer survival rates and cancer treatment-related toxicity
  • To gain an understanding of the role of the clinical nurse specialist in cardio-oncology and the need for more centres of excellence across the UK
  • To develop an awareness of the red flags that you should be aware of during cancer treatment which may indicate the need for cardio-oncology intervention.

AstraZeneca has provided a sponsorship towards this independent programme. AstraZeneca has had no editorial input into or control over the agenda, content development or choice of speakers, nor opportunity to influence except for the AstraZeneca sponsored symposia presentations. The remainder of the programme has remained under the full editorial control of the British Journal of Cardiology.

AstraZeneca has provided a sponsorship towards this independent programme. AstraZeneca has had no editorial input into or control over the agenda, content development or choice of speakers, nor opportunity to influence except for the AstraZeneca sponsored symposia presentations. The remainder of the programme has remained under the full editorial control of the British Journal of Cardiology.

 

Thanks for your feedback. Please note that by including your email address, you are giving permission for us to contact you by email to help resolve any issues.